Device Related Infection
6
0
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial
Application of Radiomics for Diagnosis and Follow-up of Cardiovascular Device Infections: PREDICT Study
Project My Heart Your Heart: Pacemaker Reuse
Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)
Antibiotic PRophylAxis Based on infeCTIve Risk in Cardiac Implantable Electronic Device
Antithrombotic Therapy in Patients Undergoing CIED Surgery - HEMATOMA NO MORE Registry